X4 Pharmaceuticals reported a gross margin of 81.64% and a net margin of -183.49% for the quarter ended Jun 2026. These financial ratios cover 38 quarters of results from Mar 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||||||||||||||||
| Gross Margin | 52.40% | 59.46% | 78.94% | 83.63% | 83.48% | 80.11% | 85.83% | 77.92% | 81.64% | |||||||||||||||||||||||||||||
| EBT Margin | 16,136.94% | -6,550.18% | -2,758.93% | 1.10% | -1,302.79% | -1,690.93% | -931.66% | -747.45% | -183.45% | |||||||||||||||||||||||||||||
| EBIT Margin | 12,629.31% | -6,160.71% | -2,490.59% | -32.78% | -1,329.55% | -1,558.58% | -922.86% | -749.85% | -186.13% | |||||||||||||||||||||||||||||
| EBITDA Margin | 12,629.31% | -6,160.71% | -2,490.59% | -32.78% | -1,329.55% | -1,558.58% | -922.86% | -749.85% | -186.13% | |||||||||||||||||||||||||||||
| Operating Margin | 12,629.31% | -6,160.71% | -2,490.59% | -32.78% | -1,329.55% | -1,558.58% | -922.86% | -749.85% | -186.13% | |||||||||||||||||||||||||||||
| Net Margin | 16,132.68% | -6,544.82% | -2,777.48% | 0.96% | -1,305.17% | -1,688.10% | -931.31% | -747.93% | -183.49% | |||||||||||||||||||||||||||||
| FCF Margin | -11,961.10% | -6,077.14% | -2,300.91% | -42.93% | -1,515.51% | -1,576.83% | -623.75% | -723.78% | -236.20% | |||||||||||||||||||||||||||||
| Efficiency | ||||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 1.64M | 2.63M | 2.95M | 3.13M | 3.62M | 4.28M | 4.56M | 5.07M | ||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 131.09M | 118.85M | 108.40M | 90.32M | 97.21M | 134.50M | 140.00M | 148.90M | 173.35M | 160.28M | 129.72M | 161.40M | 194.39M | 162.31M | 138.23M | 117.59M | 134.36M | 227.01M | 280.37M | 261.67M | ||||||||||||||||||
| Invested CapitalInvested Cap. | 102.42M | 98.35M | 85.63M | 71.18M | 108.97M | 107.87M | 84.73M | 100.80M | 122.59M | 106.10M | 56.04M | 169.48M | 134.84M | 97.57M | 98.57M | 79.81M | 137.68M | 262.58M | 244.97M | 232.21M | ||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.00 | 0.01 | 0.02 | 0.23 | 0.28 | 0.25 | 0.15 | 0.03 | 0.06 | |||||||||||||||||||||||||||||
| Leverage & Solvency | ||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -20.78 | -31.41 | -23.29 | -22.41 | -19.80 | -22.36 | -26.42 | -22.48 | -16.65 | -13.36 | -19.90 | 32.68 | -14.29 | -15.50 | -4.29 | -11.75 | -12.19 | -10.84 | -9.52 | -7.57 | ||||||||||||||||||
| Debt Ratio | 0.28 | 0.29 | 0.36 | 0.51 | 0.42 | 0.22 | 0.27 | 0.19 | 0.32 | 0.37 | 0.49 | 0.36 | 0.42 | 0.52 | 0.58 | 0.72 | 0.47 | 0.26 | 0.28 | 0.30 | ||||||||||||||||||
| Times Interest Earned | -20.78 | -31.41 | -23.29 | -22.41 | -19.80 | -22.36 | -26.42 | -22.48 | -16.65 | -13.36 | -19.90 | 32.68 | -14.29 | -15.50 | -4.29 | -11.75 | -12.19 | -10.84 | -9.52 | -7.57 | ||||||||||||||||||
| Valuation | ||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -194.36 | -53.81 | -66.77 | -42.30 | -161.21 | -65.02 | -132.79 | -171.76 | -0.00M | -233.81 | -160.99 | 38.40 | -3.08 | -3.15 | 148.75 | -0.59 | -4.97 | -7.07 | -25.75 | -36.52 | ||||||||||||||||||
| Price to SalesP/S | 0.01M | 201.40 | 87.45 | 1.43 | 7.67 | 83.85 | 65.88 | 192.60 | 67.00 | |||||||||||||||||||||||||||||
| Price to BookP/B | 57.10 | 30.00 | 32.54 | 29.83 | 57.01 | 25.56 | 61.72 | 141.69 | 79.68 | 87.53 | 0.01M | 36.93 | 1.89 | 5.66 | 1.79 | 3.81 | 2.40 | 0.91 | 3.10 | 3.80 | ||||||||||||||||||
| Enterprise Value | 3,844.87M | 1,850.58M | 1,551.07M | 849.80M | 3,446.18M | 1,770.72M | 3,096.21M | 9,432.70M | 5,254.30M | 4,373.66M | 8,279.16M | 3,340.45M | 15.37M | 69.71M | 0.80M | -24.10M | 78.36M | -47.88M | 304.66M | 394.93M | ||||||||||||||||||
| EV to EBIT | -201.10 | -63.69 | -72.93 | -41.31 | -170.99 | -69.23 | -105.66 | -365.54 | -193.07 | -173.56 | -222.03 | 46.98 | -0.45 | -1.95 | -0.08 | 0.92 | -2.85 | 2.02 | -15.00 | -24.09 | ||||||||||||||||||
| EV to EBITDA | -201.10 | -63.69 | -72.93 | -41.31 | -170.99 | -69.23 | -105.66 | -365.54 | -193.07 | -173.56 | -222.03 | 46.98 | -0.45 | -1.95 | -0.08 | 0.92 | -2.85 | 2.02 | -15.00 | -24.09 | ||||||||||||||||||
| Market Capitalization | 3,921.27M | 1,932.37M | 1,617.50M | 897.20M | 3,526.08M | 1,892.44M | 3,189.62M | 9,569.13M | 5,385.88M | 4,472.87M | 8,339.65M | 3,487.66M | 112.78M | 125.41M | 41.05M | 15.12M | 147.99M | 169.17M | 521.57M | 590.03M | ||||||||||||||||||
| Price to FCFP/FCF | -275.54 | -101.35 | -79.87 | -48.47 | -182.56 | -98.94 | -120.27 | -199.74 | -78.27 | -161.00 | -247.79 | -51.79 | -3.31 | -3.80 | -3.32 | -0.51 | -5.32 | -10.56 | -26.61 | -28.37 | ||||||||||||||||||
| EV to FCF | -270.18 | -97.06 | -76.59 | -45.91 | -178.42 | -92.58 | -116.75 | -196.89 | -76.36 | -157.43 | -245.99 | -49.60 | -0.45 | -2.11 | -0.06 | 0.81 | -2.82 | 2.99 | -15.54 | -18.99 | ||||||||||||||||||
| EV to CFO | -270.56 | -97.13 | -76.68 | -46.00 | -178.50 | -92.74 | -116.79 | -196.92 | -76.37 | -157.63 | -246.43 | -52.28 | -0.45 | -2.11 | -0.06 | 0.81 | -2.82 | 3.09 | -15.54 | -18.99 | ||||||||||||||||||
| Return Ratios | ||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | 12,629.31% | -6,160.71% | -2,490.59% | -32.78% | -1,329.55% | -1,558.58% | -922.86% | -749.85% | -186.13% | |||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -62.54% | -81.19% | -94.66% | -131.75% | -132.92% | -78.07% | -79.33% | -79.62% | -72.95% | -78.25% | -108.79% | -14.04% | -15.68% | -28.12% | -7.61% | -111.82% | -89.21% | -43.17% | -38.09% | -36.28% | ||||||||||||||||||
| Return on Invested Capital [ROIC]ROIC | -66.03% | -84.80% | -96.18% | -114.84% | -101.10% | -80.79% | -99.29% | -108.72% | -96.65% | -94.10% | -142.59% | -16.41% | -17.10% | -31.59% | -8.53% | -119.12% | -91.23% | -43.44% | -38.52% | -36.83% | ||||||||||||||||||
| Return on Assets [ROA]ROA | -58.65% | -74.63% | -84.86% | -103.58% | -97.69% | -69.79% | -68.52% | -87.59% | -64.12% | -63.12% | -99.38% | 10.92% | -8.62% | -23.07% | 10.56% | -86.72% | -70.78% | -34.89% | -35.57% | -34.45% |